Evonik Industries AG Share Price

Equities

EVK

DE000EVNK013

Specialty Chemicals

Market Closed - Xetra 16:35:29 24/05/2024 BST 5-day change 1st Jan Change
20.22 EUR +0.10% Intraday chart for Evonik Industries AG +0.40% +9.30%

Financials

Sales 2024 * 15.43B 16.73B 1,315B Sales 2025 * 15.86B 17.2B 1,351B Capitalization 9.42B 10.22B 803B
Net income 2024 * 461M 500M 39.28B Net income 2025 * 640M 694M 54.53B EV / Sales 2024 * 0.83 x
Net Debt 2024 * 3.33B 3.61B 284B Net Debt 2025 * 3.16B 3.42B 269B EV / Sales 2025 * 0.79 x
P/E ratio 2024 *
20.6 x
P/E ratio 2025 *
14.9 x
Employees 33,090
Yield 2024 *
5.8%
Yield 2025 *
5.85%
Free-Float 53.48%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.10%
1 week+0.40%
Current month+3.45%
1 month+6.42%
3 months+16.88%
6 months+14.17%
Current year+9.30%
More quotes
1 week
19.99
Extreme 19.99
20.41
1 month
19.18
Extreme 19.175
20.96
Current year
16.68
Extreme 16.68
20.96
1 year
15.79
Extreme 15.79
20.96
3 years
15.79
Extreme 15.79
30.07
5 years
15.13
Extreme 15.13
31.00
10 years
15.13
Extreme 15.13
37.75
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 31/12/12
Director of Finance/CFO 50 -
Investor Relations Contact - 31/10/11
Members of the board TitleAgeSince
Director/Board Member 74 24/05/17
Director/Board Member 71 01/06/21
Chairman 68 22/05/18
More insiders
Date Price Change Volume
24/05/24 20.22 +0.10% 850,899
23/05/24 20.2 +0.20% 1,330,581
22/05/24 20.16 -0.25% 1,001,880
21/05/24 20.21 +0.20% 3,805,045
20/05/24 20.17 +0.15% 1,445,858

Delayed Quote Xetra, May 24, 2024 at 04:35 pm

More quotes
Evonik Industries AG is a Germany-based specialty chemicals company. The Company engages in the development, construction, distribution and trade of scientific equipment, chemicals and accessories for use in the fields of life sciences and biotechnology.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
20.22 EUR
Average target price
21.73 EUR
Spread / Average Target
+7.46%
Consensus